share_log

和鉑醫藥-B：(經修訂) 截至二零二四年五月三十一日止之股份發行人的證券變動月報表

HBM HOLDINGS-B: (Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Hong Kong Stock Exchange ·  Jun 12 06:49
Summary by Moomoo AI
和鉑醫藥-B（和铂医药-B）於2024年5月31日提交了股份變動月報表，報告顯示在2024年5月期間，公司的法定/註冊股本維持不變，總額為500,000美元。已發行股份數目有所增加，從768,490,410股增至768,876,410股，增加了386,000股普通股。這些新增股份來自於首次公開發售後購股權計劃的行使，並為公司帶來了525,732港元的資金。報告由執行董事王勁松於2024年6月12日重新提交給香港交易及結算所有限公司，並確認所有交易均符合相關上市規則及法律規定。
和鉑醫藥-B（和铂医药-B）於2024年5月31日提交了股份變動月報表，報告顯示在2024年5月期間，公司的法定/註冊股本維持不變，總額為500,000美元。已發行股份數目有所增加，從768,490,410股增至768,876,410股，增加了386,000股普通股。這些新增股份來自於首次公開發售後購股權計劃的行使，並為公司帶來了525,732港元的資金。報告由執行董事王勁松於2024年6月12日重新提交給香港交易及結算所有限公司，並確認所有交易均符合相關上市規則及法律規定。
On May 31, 2024, Hepu Pharmaceuticals-B submitted a monthly report on changes in shareholding, which showed that during May 2024, the company's statutory/registered share capital remained unchanged at USD 500,000. The number of issued shares has increased from 768,490,410 shares to 768,876,410 shares, an increase of 386,000 ordinary shares. These new shares come from the exercise of the share purchase rights plan after the initial public offering, bringing the company HKD 525,732 in funding. The report was resubmitted to the Hong Kong Stock Exchange and Clearing Limited by executive director Wang Jinsong on June 12, 2024, confirming that all transactions comply with relevant listing rules and legal regulations.
On May 31, 2024, Hepu Pharmaceuticals-B submitted a monthly report on changes in shareholding, which showed that during May 2024, the company's statutory/registered share capital remained unchanged at USD 500,000. The number of issued shares has increased from 768,490,410 shares to 768,876,410 shares, an increase of 386,000 ordinary shares. These new shares come from the exercise of the share purchase rights plan after the initial public offering, bringing the company HKD 525,732 in funding. The report was resubmitted to the Hong Kong Stock Exchange and Clearing Limited by executive director Wang Jinsong on June 12, 2024, confirming that all transactions comply with relevant listing rules and legal regulations.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more